Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase III trial of Tesamorelin for the treatment of Non-alcoholic steatohepatitis (NASH) in the general population including HIV cohort

Next Previous
Search
Trial Profile

A phase III trial of Tesamorelin for the treatment of Non-alcoholic steatohepatitis (NASH) in the general population including HIV cohort

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 29 Oct 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tesamorelin (Primary)
  • Indications Fibrosis; Non-alcoholic steatohepatitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Theratechnologies

    • Most Recent Events

    • 09 Oct 2024 According to Thera Technologies media release, impact of Tesamorelin on cardiovascular disease risk prediction scores in Phase 3 Studies treatment arms: Subanalysis, will be presented in a poster session at IDWeek 2024, on Thursday, October 17, 2024, 12:15 PM -1:30 PM PT.
    • 15 Jul 2021 According to a Theratechnologies media release, this trial will include a futility analysis that will be performed after approximately 400 patients have completed 18 months of treatment and have received a second liver biopsy.
    • 15 Jul 2021 According to a Theratechnologies media release, Partner identification and negotiations will alter the initiation of the Phase 3 clinical trial that was previously expected to begin in the third quarter of calendar year 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top